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Pseudomonas aeruginosa is the most common cause of chronic and recurrent lung infections in 
patients with cystic fibrosis (CF) whose sputa contain copious quantities of P. aeruginosa toxin, 
pyocyanin. Pyocyanin triggers tissue damage mainly by its redox cycling and induction of re-
active oxygen species (ROS). The reactions between reduced glutathione (GSH) and pyocyanin 
were observed using absorption spectra from spectrophotometry and the reaction products ana-
lysed by nuclear magnetic resonance imaging. Pyocyanin reacted with GSH non-enzymatically 
at 37°C resulting in the production of red-brown products, spectophotometrically visible as a 480 
nm maximum absorption peak after 24 h of incubation. The reaction was concentration-depend-
ent on reduced glutathione but not on pyocyanin. Minimizing the accessibility of oxygen to the 
reaction decreased its rate. The anti-oxidant enzyme catalase circumvented the reaction. Proton-
NMR analysis demonstrated the persistence of the original aromatic ring and the methyl-group 
of pyocyanin in the red-brown products. Anti-oxidant agents having thiol groups produced simi-
lar spectophotometrically visible peaks. The presence of a previously unidentified non-enzymatic 
GSH-dependent metabolic pathway for pyocyanin has thus been identified. The reaction between 
pyocyanin and GSH is concentration-, time-, and O2-dependent. The formation of H2O2 as an in-
termediate and the thiol group in GSH seem to be important in this reaction.
Keywords: catalase, superoxide dismutase, glutathione, Pseudomonas aeruginosa pyocyanin, cystic fibrosis, oxidative stress, 
spectrophotometry, nuclear magnetic resonance imaging
INTROduCTION
Chronic Pseudomonas aeruginosa infections oc-
cur frequently with the immunocompromised, the 
aged, and those with cystic fibrosis (CF) (Lyczak 
et al., 2002), bronchiectasis (Khalid et al., 2004), and 
otitis externa (Beers & Abramo, 2004). Antibiotic-re-
sistant P. aeruginosa infections are a major source of 
concern (Conway et al., 2003). P. aeruginosa secretes 
a number of virulence factors, including elastases, 
rhamnolipids, alginate, exotoxin A, exoenzyme S, 
and phospholipase C, whose virulent properties 
have been elucidated well (Lyczak et al., 2000; Lau 
et al., 2004). Yet, neither the precise virulent proper-
ties, nor the in vivo metabolic fate of pyocyanin, a 
redox active blue-green phenazine pigment secreted 
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by P. aeruginosa in copious quantities in infected CF 
patients (Pitt, 1986; Wilson et al., 1988), have been 
charted adequately. 
Sputum sol phase pyocyanin concentrations 
from patients with CF colonized by P. aeruginosa 
can go up to 27.3 µg/ml (≈ 130 µM) (Wilson et al., 
1988). These concentrations are much more than 
adequate to inhibit ciliary beating as demonstrable 
in vitro (Wilson et al., 1987). Pyocyanin exerts di-
verse cytotoxic effects mediated mainly through its 
redox activity and reactive oxygen species (ROS)-
inducing capability (Mahajan-Miklos et al., 1999; 
O’Malley et al., 2004). Pyocyanin inhibits cell respira-
tion (Sorensen & Klinger, 1987), inactivates catalase 
(O’Malley et al., 2003), inhibits prostacyclin release 
(Kamath et al., 1995), and disrupts lung epithelial 
cell growth (Wilson et al., 1988), calcium homeostasis 
(Denning et al., 1998) and ciliary function (Wilson et 
al., 1987). Pyocyanin facilitates P. aeruginosa coloni-
zation of the respiratory tract by significantly reduc-
ing tracheobronchial mucus velocity (Munro et al., 
1989). Pyocyanin inactivates protease inhibitors and 
contributes to a protease-antiprotease activity imbal-
ance, resulting in lung epithelial injury (Britigan et 
al., 1999). Two in vivo murine respiratory tract infec-
tion models, acute and chronic, have demonstrated 
the absolute necessity of pyocyanin biosynthesis for 
P. aeruginosa virulence (Lau et al., 2004). 
Glutathione (GSH), a ubiquitous tripeptide 
intracellular and extracellular thiol, constitutes 90% 
of intracellular nonprotein thiols (Meister & An-
derson, 1983). In a reaction catalyzed by GSH per-
oxidase (GPx), GSH converts hydrogen peroxide to 
water, and lipid peroxides to nontoxic hydroxy fatty 
acids (Zachara et al., 2006). In addition to this most 
important anti-oxidant function, GSH also impedes 
antiprotease-degradation (Buhl et al., 1990) and as-
sists in maintaining lung surfactant (Jain et al., 1992). 
GSH levels in the extracellular lung fluid (eLF) 
range from 250 to 800 µM with a mean of 429 µM 
for patients not under oxidative stress, and a mean 
of 800 µM for patients under oxidative stress (Roum 
et al., 1993; Morrison et al., 1999). This is significant-
ly higher than the normal plasma GSH range of 2–
5 µM (Samiec et al., 1998). The total eLF glutathione 
(96% GSH + 4% glutathione disulfide GSSG) is at 
least 140 times more than the plasma concentration 
(Cantin et al., 1987). Although the eLF GSH levels 
are slightly lower in CF patients when compared to 
normal individuals (Roum et al., 1993), a normal lev-
el of intracellular GSH (2–10 mM) is present in CF 
epithelial cells (Gao et al., 1999). In CF patients, both 
spontaneous and induced sputum samples contain 
higher GSH levels than samples from healthy con-
trols (Dauletbaev et al., 2004).
Since pyocyanin is produced in large amounts 
in CF pseudomonal infections (Pitt, 1986; Wilson et 
al., 1988), these differences in GSH levels in the eLF 
and bronchoalveolar secretions could be easily and 
frequently perturbed by acute or chronic pyocyanin-
induced epithelial and endothelial damage, result-
ing in GSH release from the lysed cells. Pyocyanin 
(12.5 µM or more, 30 min-incubation) significantly 
decreases human umbilical venous endothelial cell 
GSH level (Muller, 2002). Pyocyanin (30 µM or more, 
24 hour-incubation) significantly decreases intracel-
lular GSH in the respiratory cell-line A549 (O'Malley 
et al., 2004). Pyocyanin concentrations of 30 µM or 
more significantly increase extracellular GSH export 
and GSSG concentrations in A549 cells (O'Malley et 
al., 2004). Those authors demonstrated a prompt di-
rect reaction between pyocyanin and GSH, resulting 
in the formation of thiyl, pyocyanin, and superox-
ide radicals. Both Muller (2002) and O’Malley et al. 
(2004) reported the results of experiments involving 
pyocyanin and GSH only that were incubated for 
less than an hour. Yet in CF patients, P. aeruginosa, 
secreting pyocyanin, lingers for long periods of time 
causing recurrent remissions and exacerbations. We 
simulated this scenario by demonstrating a reaction 
between pathophysiologically relevant concentra-
tions of pyocyanin and GSH over a period of days, 
rather than minutes or hours.
In our study, we show a reaction of pyocyanin 
with GSH in phosphate buffer (pH 7.4), at 37°C, ob-
served over a period of days under pathophysiologi-
cally relevant conditions using spectrophotometry. 
We also investigated the effect of oxygen concentra-
tion, reactant concentrations, anti-oxidant enzymes, 
and pH on the reaction. We also report our attempts 
to purify and analyze the reaction products using 
nuclear magnetic resonance (NMR) imaging.
MeTHOdS
Synthesis of pyocyanin. Pyocyanin was 
chemically synthesized by photolysis of phenazine 
methosulfate (Knight et al., 1979) and purified (Mull-
er & Sorrell, 1992) as described earlier. Briefly, phen-
azine methosulfate (P-9625-5g, Sigma-Aldrich Pt Ltd, 
Sydney, Australia) was made up in 0.01 M Tris/HCl 
buffer (pH 7.4) in a round-bottomed Pyrex flask and 
exposed to fluorescent tube light (Phillips TLD 18 
W/54) for 2.5 h. The resulting solution was extracted 
into chloroform and vacuum-dried to a powdery 
residue. The residue was dissolved in chloroform 
and acidified with an equal volume of 0.1 M HCl. 
The red acidic form of pyocyanin was converted into 
the blue form using 0.5 M NaOH. This blue form of 
pyocyanin, now in the aqueous phase, was extracted 
into chloroform and this cycle repeated 3 times. The 
blue form of pyocyanin which was extracted into 
chloroform the last time was vacuum dried, washed 
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as well as precipitated with hexane, trapped on a 
type eH 0.5 µm filter, reconstituted in chloroform 
and purified by thin-layer chromatography (TLC) 
using an equimolar chloroform/methanol mixture 
solvent. The pyocyanin thus purified was stored in 
methanol at –70°C. The purity of pyocyanin was as-
certained and its concentration quantitated by utiliz-
ing its known absorption spectrum and absorption 
coefficient values as elucidated earlier (Watson et al., 
1986). Before use, the methanol solvent was removed 
by nitrogen insufflation and when completely dry, 
pyocyanin was reconstituted in saline and used.
Glutathione-pyocyanin reactions. All reac-
tions were done in triplicate. Pyocyanin concentra-
tions used were 0–125 µM to cover previously es-
timated in vivo concentrations (Wilson et al., 1988). 
GSH concentrations utilized were 0–10 mM to cover 
concentration ranges in CF eLF (Roum et al., 1993), 
CF epithelial cells (Gao et al., 1999) and in sponta-
neous and induced sputa (Dauletbaev et al., 2004). 
Most reactions had 25 µM pyocyanin and 10 mM 
GSH as the reactants. All incubation mixtures were 
incubated in well-covered 1 cm plastic cuvettes, un-
less otherwise specified. Incubation of all reactions 
was done in phoshate buffer solution (PBS, 125 mM 
KH2PO4, pH 7.4) at 37°C in the dark. For oxygen-
deprived reactions, nitrogen was bubbled through 
the reaction mixtures, followed by addition of a 3 
cm mineral oil layer on top of each final reaction 
mixture before incubation. Reaction mixtures were 
transferred to plastic cuvettes to measure the ab-
sorbance spectra using a Shimadzu UV120 IPC 
spectrophotometer with the following calibrations: 
Measuring Mode — Abs, Recording Range — Low 
0.0 to High 0.5, Wavelength Range (nm) — 800–200 
nm, Scan Speed — Fast and Sampling Interval — 1 
nm. The absorption spectra presented throughout 
this study are representatives of triplicates. The 
reaction rates and constants were deliberately not 
calculated owing to the obvious slow reaction time 
and the chronicity of the pathophysiological sce-
nario.
Purification of glutathione-pyocyanin reac-
tion products. The red-brown GSH-pyocyanin reac-
tion products were purified from up-scaled 10 ml 
reaction mixtures (concentrations of reactants in-
creased 10-fold) with the discovery that a Tris/HCl 
(10 mM, pH 3) wash prior to acidified (2% acetic 
acid) aqueous methanol elution of the GSH-pyocy-
anin reaction products removes glutathione, both 
reduced and oxidized. The presence or absence of 
glutathione is easily discernable by the presence 
or absence of the 230 nm peak or by the ninhydrin 
test. Each up-scaled reaction mixture consisted of 
10 ml of PBS with 250 µM pyocyanin and 100 mM 
GSH (final pH = 7.4), incubated at 37°C in a loosely 
capped 50 ml conical bottom Falcon polypropyl-
ene tube for 36–48 h. After several attempts, puri-
fication of the red-brown species from the reactant 
remnants and other products involved the follow-
ing solid phase extraction (SPe) method: A poly-
mer based SPe column (Oasis HLB 3cc cartridges 
from Waters company) was determined to be the 
best available method to purify the red-brown spe-
cies by utilizing the following protocol (for each 
Oasis HLB 3cc cartridge): (1) CH3OH: 1 ml, (2) Mil-
lipore water: 1 ml, (3) up-scaled pyocyanin-GSH re-
action mixture: 1 ml, (4) Tris/HCl wash: 1 ml, (5) 
PBS (pH = 7.4) wash: 5 ml, (6) Millipore water: 1 ml, 
(7) acidified 60% methanol elute solution: 1 ml, and 
(8) speed vacuum drying.
Ninhydrin test. The ninhydrin test is a test for 
the presence or absence of the amino (–NH2) group 
and hence should be positive if glutathione (GSH or 
GSSG) is present. A crude qualitative visual test that 
we utilized for testing for the presence or absence 
of glutathione was done by heating 0.5 ml of the 
sample with 0.5 ml of ninhydrin (triketohydrindene 
hydrate; Sigma-Aldrich, St. Louis, MO, USA) in ac-
etone with 1% acetic acid up to 45°C in a glass tube 
and observing color changes. In this adaptation of 
the ninhydrin test, a dark red-brown color change 
indicates the presence of abundant amino (–NH2) 
groups in the sample. This crude test was positive 
only when amino groups were abundant.
Chemicals and enzymes. Glutathione (GSH 
and GSSG), N-acetylcysteine (NAC), dithiothreitol 
(DTT), superoxide dismutase (SOD), and catalase 
(CAT) were purchased from Sigma-Aldrich (St. Lou-
is, MO, USA). TLC plates (Silicagel 20 × 20 cm) were 
obtained from Crown Scientific (Moorebank, NSW, 
Australia).
Nuclear magnetic resonance imaging. All 
proton NMR (1H solution) spectra were done at 
25oC using a Bruker DRX 300 MHz NMR instru-
ment. Deuterium oxide (Sigma Aldrich) was consist-
ently used as the solvent. The internal standard was 
the sodium salt of 3-(trimethylsilyl) 3,3,2,2-tetradeu-
teroproponic acid. The typical acquisition parameters 
utilized were spectral width 4000 Hz, repetition time 
2 s and line broadening frequency 0.5 Hz. 
ReSulTS
Glutathione and pyocyanin reaction
GSH reacts with pyocyanin non-enzymati-
cally after 24 h of incubation at 37°C, resulting 
in formation of red-brown products, visible spec-
tophotometrically as a 480 nm peak (Fig. 1e and 
G). Figure 1A and B represent 10 mM GSH-only 
controls under aerobic and oxygen-deprived con-
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ditions, respectively. Figures 1C and D represent 
25 µM pyocyanin-only controls under aerobic and 
oxygen-deprived conditions, respectively.
Time-course experiments involving glutathione and 
pyocyanin
GSH and pyocyanin were incubated at 37°C 
over 96 h under normal aerobic conditions or oxy-
gen-deprived conditions, with absorption spectra 
recorded 24-hourly. The production of the 480 nm 
peaks, coinciding with the formation of the visible 
red-brown products, was much faster under aero-
bic conditions (Figs. 1e and G) in contrast to oxy-
gen-deprived conditions (Fig. 1F and H).
dose-response experiments involving glutathione 
and pyocyanin
Dose-response experiments were done in-
volving GSH and pyocyanin at 37°C over 96 h 
under normal aerobic conditions. Production of 
the 480 nm peak, coinciding with the formation 
of the visible red-brown products, was dependent 
only on the concentration of GSH (Fig. 2A) but 
not on the concentration of pyocyanin (Fig. 2B). 
Figure 1. Time-course experiments involving GSH and pyocyanin.
GSH and pyocyanin were allowed to react at 37°C over 96 h with absorption spectra recorded 24-hourly. A and B, 10 
mM GSH-only controls under aerobic and oxygen-deprived conditions, respectively. C and D, 25 µM pyocyanin-only 
controls under aerobic and oxygen-deprived conditions, respectively. e and F, 25 µM of pyocyanin reacting with 10 mM 
GSH under aerobic and oxygen-deprived conditions, respectively, demonstrating that the reaction producing the 480 nm 
absorption peak was much faster under aerobic conditions than anaerobic conditions. G and H, Complete spectra shown 
in part as e and F, respectively.
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The effect of anti-oxidant enzymes on the glutath-
ione-pyocyanin reaction and the effect of pH varia-
tions on the reaction products
SOD did not prevent the 72-h GSH-pyocyanin 
reaction from occurring but a combination of SOD 
and catalase did (Fig. 3A), pointing to the impor-
tance of H2O2 but not superoxide in the reaction. 
A completely and repeatedly demonstrable pH-de-
pendant (pH 2 to 9) reversible shift in the complete 
absorption spectra of a diluted sample of the red-
brown GSH-pyocyanin reaction products was evi-
dent (Fig. 3B), suggesting active electron resonance 
in the reaction products. 
Purification of glutathione-pyocyanin reaction prod-
ucts
Solid-phase extraction procedures involving 
various concentrations, proportions and combinations 
of methanol, chloroform, ethyl acetate and acetone 
were done before ascertaining that acidified methanol 
was the best eluant for solid-phase-trapped red-brown 
GSH-pyocyanin reaction products. The more the aque-
Figure 2. dose-response experiments in-
volving GSH and pyocyanin.
GSH and pyocyanin were allowed to 
react at 37°C over 96 h under aerobic 
conditions. A. Absorption spectra for 25 
µM pyocyanin treated with increasing 
concentrations of GSH. Production of the 
480 nm peak was dependent on the con-
centration of GSH. B. Absorption spectra 
for 10 mM GSH treated with increasing 
concentrations of pyocyanin. Production 
of the 480 nm peak did not seem to be 
dependent on the concentration of pyo-
cyanin.
Figure 3. The effect of anti-oxidant enzymes 
on the GSH-pyocyanin reaction and the ef-
fect of pH variations on the reaction prod-
ucts.
A. SOD did not prevent the 72-h GSH-pyo-
cyanin reaction from occurring but a com-
bination of SOD and catalase did. B. pH-
dependant reversible shift (pH 2 to 9) in 
absorption spectra of diluted sample of the 
red-brown GSH-pyocyanin reaction prod-
ucts.
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ous dilution of acidified methanol (2% acetic acid), the 
better the elution efficacy of the trapped red-brown 
GSH-pyocyanin reaction products trapped in the Oa-
sis HLB 3cc cartridges (Figs. 4A and B). Having estab-
lished that acidified 60% methanol was the most ap-
propriate eluant (Figs. 4A and B) owing to the ease in 
extracting the dry reaction products from 60% metha-
nol compared to more aqueous solutions, the problem 
Figure 4. Purification of GSH-pyocyanin reaction products.
A and B. Demonstration of the efficacy of increasing dilutions of aqueous acidified methanol to elute the red-brown 
GSH-pyocyanin reaction products trapped in the Oasis HLB 3cc cartridges. B. Cartridges 1 to 10 arranged in order of 
increasing dilutions of acidified methanol demonstrating that more the aqueous dilution of acidified methanol, the better 
the elution efficacy of the trapped red-brown GSH-pyocyanin reaction products. However, owing to the ease in extract-
ing the dry GSH-pyocyanin reaction products from 60% methanol compared to more aqueous solutions, this dilution of 
acidified methanol was used subsequently. C and D. Spectra of 60% acidified methanol eluted GSH-pyocyanin reaction 
products with or without Tris/HCl (10 mM, pH 3) removal of residual glutathione. Absence of residual glutathione was 
confirmed by the absence of the 230 nm absorption peak and a negative ninhydrin test. D. Complete spectra shown in 
part as C. 
Figure 5. Proton NMR analysis of the 
red-brown GSH-pyocyanin reaction 
products.
Proton NMR spectra of GSH (A), GSSG 
(B), Pyocyanin (C) and red-brown 
GSH-pyocyanin reaction products (D). 
The singlet peak at δ 4.14 ppm, corre-
sponding to the methyl group in pyo-
cyanin (C), shifts upfield in the red-
brown GSH-pyocyanin reaction prod-
ucts (D) with additional peaks in the 
latter (δ 2.14, 2.53, 3.82, 4.21 and 4.81) 
corresponding to GS in the red-brown 
GSH-pyocyanin reaction products. 
The multiple peaks around δ 7.64–8.21 
ppm, indicative of the aromatic region 
of the pyocyanin (C), shifted downfield 
in the red-brown GSH-pyocyanin reac-
tion products (D).
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of co-elution of the original reactants (both reduced 
and oxidized glutathione) with the products was pre-
cluded only after the discovery that Tris/HCl (10 mM, 
pH 3) removes glutathione (GSH and GSSG). The ab-
sence of residual glutathione can be inferred from the 
absence of the 230 nm absorption peak (Figs. 4A and 
4D; Fig. 4C is a magnified circumscribed version of 
Fig. 4D), after Tris/HCl treatment and subsequent acid-
ified aqueous methanol elution of the GSH-pyocyanin 
reaction red-brown products. These products were 
also ninhydrin test-negative suggesting the absence of 
abundant amino group and hence, glutathione.
Properties of glutathione-pyocyanin reaction products
The purified red-brown products were insolu-
ble in methanol, chloroform, ethyl acetate, acetone, 
and a number of organic solvents, but very soluble 
in water.
Nuclear magnetic resonance analysis of the red-
brown glutathione-pyocyanin reaction products
A comparison of the proton NMR spectra of 
GSH (Fig. 5A), GSSG (Fig. 5B), pyocyanin (Fig. 5C) 
and the red-brown GSH-pyocyanin reaction products 
(Fig. 5D) provides an indication of the appropriate as-
signments to the red-brown GSH-pyocyanin reaction 
products. The singlet peak at δ 4.14 ppm, which cor-
responds to the methyl group in pyocyanin (Fig. 5C), 
shifts upfield in the red-brown GSH-pyocyanin reaction 
products (Fig. 5D) due to the disappearance of the pos-
itive charge from the amine group. In the NMR spec-
tra of the red-brown GSH-pyocyanin reaction products 
(Fig. 5D), five peaks at δ 2.14, 2.53, 3.82, 4.21 and 4.81 
can be assigned to the GS bond to the pyocyanin ow-
ing to similar peaks produced by GSH and GSSG. Fur-
thermore, the multiple peaks around δ 7.64–8.21 ppm, 
indicative of the aromatic region of the pyocyanin (Fig. 
5C), shifted downfield in the red-brown GSH-pyocy-
anin reaction products (Fig. 5D). This downfield shift 
in the aromatic region of the NMR spectra may be the 
characteristic feature of the new net positive charge of 
the red-brown GSH-pyocyanin reaction products. 
Reactions of pyocyanin with other thiol anti-oxidant 
agents
Thiol anti-oxidant agents N-acetylcysteine 
(Fig. 6A) and dithiothreitol (Fig. 6B) produced ab-
Figure 6. Reactions of pyocyanin with other thiol 
anti-oxidant agents
At 37°C over 96 h under aerobic conditions, thiol 
anti-oxidant agents N-acetylcysteine (A) and dithi-
othreitol (B) produced absorption peaks at 470 nm 
and 450 nm respectively, with 30 µM pyocyanin.
Figure 7. Proposed reaction of pyocyanin 
with GSH.
Hydrogen from the thiol (–SH) group of 
GSH reacts with the first nitrogen atom of 
pyocyanin. The hydroquinone pyocyanin 
structure is oxidized to a quinone struc-
ture, adding a whole GS molecule to the 
ortho-position of the quinone red-brown 
products, with a re-arranging of covalent 
carbon bonds.
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sorption peaks with 30 µM pyocyanin (37°C; 96 h; 
normal aerobic conditions) at 470 nm and 450 nm 
respectively, demonstrating that the thiol group may 
be important in these reactions.
dISCuSSION
Pyocyanin reacted non-enzymatically with 
GSH resulting in formation of red-brown products, 
visible spectophotometrically as a 480 nm peak re-
corded after 24 h of incubation at 37°C. The reaction 
was concentration-dependent on GSH. Decreasing 
oxygen availability decelerated the reaction. The red-
brown products also demonstrated an absorption 
spectral shift with pH changes. The red-brown prod-
ucts were insoluble in methanol, chloroform, ethyl 
acetate, acetone, and a number of organic solvents, 
but very soluble in water. Catalase circumvented the 
reaction demonstrating the importance of H2O2 in 
this reaction. Redox cycling of pyocyanin utilizing 
cellular reductants results in the production of abun-
dant quantities of H2O2 which can be used in this re-
action (Muller, 2002). Thiol group-containing agents 
such as NAC and DTT produced similar reactions 
showing that the thiol group may be important in 
this reaction. Proton-NMR analysis clearly depicted 
the persistence of the original aromatic ring and the 
methyl group of pyocyanin in the red-brown prod-
ucts. Hydrogen from the thiol group of GSH or a 
possible thiyl radical that may have formed in the 
reaction between pyocyanin and GSH (O’Malley et 
al., 2004) may react with the first nitrogen atom of 
pyocyanin (Fig. 7). GSH probably reacts with the 
hydroquinone pyocyanin structure producing a qui-
none structure, resulting in a whole GS molecule be-
ing added to the ortho-position of the quinone red-
brown products in the process.
Pyocyanin, which is produced in large 
amounts in CF pseudomonal infections (Pitt, 1986; 
Wilson et al., 1988), exerts manifold cytotoxic effects 
mediated through redox cycling and ROS induction 
(Britigan et al., 1992; Mahajan-Miklos et al., 1999; 
Muller, 2002). Pyocyanin alters specific immune de-
fences, and potentiates and perpetuates harmful in-
flammatory reactions in the infected CF lung. Yet 
the in vivo metabolic fate of pyocyanin has not been 
elucidated till now. 
Lung epithelial, endothelial, and eLF GSH ex-
erts significant cytoprotective antioxidant, surfactant 
stabilizing, anti-protease protecting and mucolytic 
activity (Meister & Anderson, 1983; Rahman & Mac-
Nee, 2000). Abnormal and low GSH levels can lead 
to crippling of the lung’s antioxidant system, anti-
protease system (Konstan et al., 1994; Birrer, 1995), 
message transmission and immune recognition sys-
tem (Barbero, 1994), mucolytic system (Hudson, 
2001; 2004), and surfactant secretion system (Jain et 
al., 1992). The end results of low GSH levels include 
pulmonary damage, exacerbation of extant pseu-
domonal infections and a drastically increased pro-
pensity to contract infections. Since pyocyanin has a 
profound ability to modulate the glutathione redox 
cycle and deplete intracellular GSH in endothelial 
cells (Muller, 2002) and intracellular and extracel-
lular GSH in lung epithelial cells (O’Malley et al., 
2004), it is reasonable to expect lower GSH levels in 
eLF from CF patients with P. aeruginosa infection. 
Although eLF has decreased GSH levels (Gao et al., 
1999) compared to intracellular GSH levels in CF 
lung epithelia, CF sputum samples have higher GSH 
levels than healthy sputum samples (Dauletbaev et 
al., 2004). The latter discrepancies could be accentu-
ated by pyocyanin-induced epithelial (Hingley et al., 
1986; Wilson et al., 1987) and endothelial (Britigan 
et al., 1992; Miller et al., 1996; Muller, 2002) necrosis 
and apoptosis, resulting in GSH release. Since nor-
mal intracellular GSH concentration ranges from 2 
to 10 mM (Gao et al., 1999), released cellular GSH 
would probably be present in high concentrations 
for a non-enzymatic reaction with pyocyanin in the 
setting of a persistent P. aeruginosa infection linger-
ing in the CF lung. 
While pyocyanin is very soluble in water, 
methanol and chloroform, the purified red-brown 
products were insoluble in most organic solvents. 
Yet the red-brown products were very soluble in 
water, attesting to the polarity of the same and sug-
gesting that this reaction is probably a pyocyanin 
detoxification mechanism. Preliminary studies with 
NADPH show a significant drop in the oxidative po-
tential of the red-brown products when compared to 
that of pyocyanin. Therefore the red-brown products 
may be the result of a previously unknown oxygen-
dependent, non-enzymatic pyocyanin detoxification 
system involving GSH. Consequentially, the pro-
duction of pyocyanin in the airways of CF patients 
may be much higher than previously assessed (Pitt, 
1986; Wilson et al., 1988), because the presence of the 
red-brown products has not been accounted for by 
the methodologies used till now. Neither the red-
brown products produced during this reaction, nor 
the magnitude of GSH concentration fluctuations in 
CF patients with P. aeruginosa infections, have been 
estimated yet. This can be the next research course 
to pursue.
To conclude, the presence of a possible non-
enzymatic GSH-dependent pathway for P. aeruginosa 
pyocyanin conversion has been identified. This path-
way is time-, concentration-, and O2-dependent. The 
formation of H2O2 as an intermediate is necessary 
for this reaction. The thiol group of GSH seems to 
be important in this reaction. The original aromatic 
ring and the methyl group of pyocyanin persist in 
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the red-brown reaction products. Strategies to inhib-
it pyocyanin production and to facilitate pyocyanin 
metabolism to neutralize its toxicity by GSH and 
other antioxidant therapies may be incorporated into 
existing regimens for the treatment of CF (Conway, 
1999; Roum et al., 1999; Rahman & MacNee, 2000). 
If the red-brown products prove to be substantially 
less pathogenic than pyocyanin in future research, 
the utilization of aerosolized, spaced, or nebulized 
GSH could be viable therapeutic options in chronic 
pseudomonal lung infections.
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